Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: A parallel, open-label randomised controlled trial

The Lancet

Volumn 380, Issue 9857, 2012, Pages 1909-1915

  Laharie, David ^a,b   Bourreille, Arnaud ^c   Branche, Julien ^d   Allez, Matthieu ^e   Bouhnik, Yoram ^f   Filippi, Jerome ^g   Zerbib, Frank ^h   Savoye, Guillaume ⁱ   Nachury, Maria ^j   Moreau, Jacques ^k   Delchier, Jean Charles ^l   Cosnes, Jacques ^m   Ricart, Elena ^n,o   Dewit, Olivier ^p   Lopez Sanroman, Antonio ^q   Dupas, Jean Louis ^r   Carbonnel, Franck ^s   Bommelaer, Gilles ^t   Coffin, Benoit ^u   Roblin, Xavier ^v   Van Assche, Gert ^w   Esteve, Maria ^x   Färkkilä, Martti ^y,z   Gisbert, Javier P ^aa   Marteau, Philippe ^ab   Nahon, Stephane ^ac   De Vos, Martine ^ad   Franchimont, Denis ^ae   Mary, Jean Yves ^af   Colombel, Jean Frederic ^d   Lémann, Marc ^ag   more..

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔTEL DIEU   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f BEAUJON HOSPITAL   (France)

^g CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^h HÔPITAL SAINT ANDRÉ   (France)

ⁱ UNIVERSITÉ DE ROUEN   (France)

^j UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^k CHU RANGUEIL   (France)

^l HENRI MONDOR HOSPITAL   (France)

^m HÔPITAL SAINT ANTOINE   (France)

ⁿ HOSPITAL CLÍNIC   (Spain)

^o INSTITUTO DE SALUD CARLOS III   (Spain)

^p CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^q HOSPITAL RAMÓN Y CAJAL   (Spain)

^r AMIENS UNIVERSITY HOSPITAL   (France)

^s BICÊTRE HOSPITAL   (France)

^t UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^u HÔPITAL LOUIS MOURIER   (France)

^v HÔPITAL NORD   (France)

^w UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^x HOSPITAL MÚTUA DE TERRASSA   (Spain)

^y UNIVERSITY OF HELSINKI   (Finland)

^z HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^aa HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^ab HÔPITAL LARIBOISIÈRE   (France)

^ac Centre Hospitalier Intercommunal Le Raincy Montfermeil   (France)

^ad GHENT UNIVERSITY HOSPITAL   (Belgium)

^ae ERASME HOSPITAL   (Belgium)

^af INSERM   (France)

^ag NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INFLIXIMAB; STEROID;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COLITIS; COLON RESECTION; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OSTEOARTHRITIS; PARALLEL DESIGN; PERIANAL ABSCESS; PNEUMONIA; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SEPTICEMIA; SIDE EFFECT; STEROID THERAPY; TREATMENT RESPONSE; ULCERATIVE COLITIS; URINARY TRACT INFECTION; VENOUS THROMBOEMBOLISM;

EID: 84870293844     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61084-8     Document Type: Article

References (34)

1. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011; 365: 1713-25.
2. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963; 4: 299-315.
3. Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis 2010; 4: 431-37.
4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. BMJ 1955; 2: 1041-48.
5. D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001; 120: 1323-29. (Pubitemid 32322305)
6. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-45. (Pubitemid 24188135)
7. Van Assche G, D'Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003; 125: 1025-31. (Pubitemid 37193449)
8. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805-11. (Pubitemid 40824691)
9. Travis SP, Stange EF, Lemann M, et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohn Colitis 2008; 2: 24-62. (Pubitemid 351179488)
10. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-23.
11. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn Colitis 2009; 3: 47-91.
12. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317: 1625-29. (Pubitemid 18010466)
13. Siegel S. Non parametric statistics for the behavioral sciences. New York: McGraw-Hill Book Co, 1956.
14. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Rep 1966; 50: 163-70.
16. Cox DR. Regression models and life-tables (with discussions), series B. J R Stat Soc 1972; 34: 184-92.
17. Cox DR, Snell EJ. Analysis of binary data. London, Chapman & Hall, 1989.
18. Dupont WD, Plummer WD. Power and sample size calculations. A review and computer program. Control Clinical Trials 1990; 11: 116.
19. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53. (Pubitemid 43764536)
20. Actis GC, Bresso F, Astegiano M, et al. Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther 2001; 15: 1307-11. (Pubitemid 32835536)
21. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999; 94: 1587-92. (Pubitemid 29260450)
22. Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006; 55: 47-53. (Pubitemid 41820634)
23. Cacheux W, Seksik P, Lemann M, et al. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol 2008; 103: 637-42. (Pubitemid 351405993)
24. Probert CS, Hearing SD, Schreiber S, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut 2003; 52: 998-1002. (Pubitemid 36765292)
25. Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001; 7: 83-88.
26. Kohn A, Daperno M, Armuzzi A, et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 2007; 26: 747-56. (Pubitemid 47246204)
27. Su C, Salzberg BA, Lewis JD, et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 2002; 97: 2577-84.
28. Gornet JM, Couve S, Hassani Z, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study. Aliment Pharmacol Ther 2003; 18: 175-81. (Pubitemid 36951653)
29. Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis. Inflamm Bowel Dis 2005; 11: 213-18. (Pubitemid 40439675)
30. Jakobovits SL, Jewell DP, Travis SP. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 2007; 25: 1055-60. (Pubitemid 46587696)
31. Oussalah A, Evesque L, Laharie D, et al. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization. Am J Gastroenterol 2010; 105: 2617-25.
32. Panaccione R, Ghosh S, Middleton S, et al. Infliximab, azathioprine, or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: the UC SUCCESS trial. J Crohn Colitis 2011; 5: S8.
33. Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004; 10: 73-78. (Pubitemid 38332164)
34. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132: 507-15.